Getting IP licensing right for university spin outs

Although discussions around spin‑outs have often focussed on headline equity splits, difficulties later down the line more often arise from how ongoing IP rights, control provisions and economic terms are structured at the outset. 

For university technology transfer offices (TTOs), in-house legal teams, founders and investors alike, these early legal decisions can shape outcomes years later. The importance of getting these issues right has also been underscored by the significant impact of the UK university spinout investment terms (USIT) guide as a reference point for more consistent market practice. 

Below we consider some of the legal considerations that frequently determine whether a university spin-out’s IP framework supports long-term growth or could inadvertently restrict it.

Spin-out licensing – a distinct legal context 

University spin‑outs differ in important respects from conventional founder-led start-ups. In most cases, key IP is owned by the university under employment contracts, institutional IP policies and sometimes funder, regulatory or other legal obligations. Universities are therefore not simply commercial counterparties: they are stewards of public or charitable assets, subject to governance, audit and regulatory constraints. 

Against this backdrop, spin-out licensing is best understood not simply as the licensing of an IP asset, but as an exercise in managing future outcomes and risks, while recognising the university’s prior investment in generating and protecting the underlying IP and its impact. 

At formation, neither party can know whether the technology will fail, pivot, scale rapidly, or require multiple rounds of capital. The challenge is to put in place a structure that can accommodate different outcomes without the need for future renegotiations. 

Licence or assignment

The fundamental question of whether spin‑outs should receive licensed or assigned IP is often presented as a binary choice. However, from a legal perspective the more useful question is how different structures affect risk allocation, practical control and future operability. 

Universities may seek to retain ownership not simply as a matter of formal title, but to reflect prior institutional investment, preserve reversionary rights, maximise impact, satisfy governance and funder constraints, and maintain flexibility over how strategically significant IP is exploited. 

Investors may focus less on formal ownership than on whether the company has the practical control needed to build value through exclusivity, sub-licensing freedom, certainty on change of control, and clear rights over future development and improvements. 

In practice, a sufficiently broad exclusive licence can replicate many of the commercial and operational attributes of an assignment. This requires drafting with appropriate scope, duration, sub-licensing rights, treatment of improvements, and workable provisions on enforcement, change of control and termination. 

Conversely, a poorly drafted licence can create uncertainty, hinder investment and hamper commercialisation, even where intentions were originally aligned. In practice, the drafting, rather than the label, is often decisive. 

Commercial considerations

Spin-out transactions frequently involve multiple overlapping commercial considerations: equity, royalties, milestones, anti-dilution, and reimbursement of historic costs. Each of these mechanisms may be commercially justified in isolation, but difficulties can arise due to the way they may impact when the spin-out later seeks funding or pursues growth.    

By way of example, a university may take a modest founding equity stake and also negotiate a running royalty on product revenues. Each term is likely to be justified, but investors may become concerned if the combined effect is for the equity in the spin-out to become heavily diluted at or shortly after formation and subject to an ongoing revenue burden as it grows. 

More immediate concerns can arise where the spin-out is required to reimburse historic patent prosecution or maintenance costs at a point when cashflow is still tight in the early stages of the business. Even where reimbursement is justified in principle, front-loading that obligation can place immediate pressure on working capital before the company has secured investment and/or stable revenue.  

There is growing recognition that economic rights should be assessed holistically, rather than treating the IP licence and investment documentation as separate exercises. The earlier the parties can agree on these key financial issues, the less likely they are to encounter avoidable friction later on. 

Issues can also arise if future know-how, improvements or follow-on IP are not clearly allocated or sufficiently addressed in a way that is workable for both parties, particularly where uncertainty over who benefits from later developments risks disincentivising further innovation and creating tension as the spin-out grows.  

Oversight, consents and reserved rights 

Universities often include a number of protective rights in spin out licences. These are designed to protect the IP if the spin-out fails, underperforms or breaches key obligations; to satisfy governance and funder requirements; to reserve academic rights of research, teaching and publication; and to retain oversight of how strategically important IP is developed.

These rights may require the spin-out to obtain consent before taking certain steps, permit intervention if the IP is not being properly developed or protected or allow rights to revert in tightly defined circumstances. Such protections are often necessary. The legal challenge is to draft them to address genuine risk without creating unnecessary obstacles to investment or commercial progress. 

Many of the issues that create difficulty later, particularly around sub-licensing, change of control, enforcement and improvements, are best addressed in the licence at formation rather than revisited under transactional pressure. 

Carefully scoped provisions such as objective consent standards, clearly defined triggers, and rights that may be reduced or relaxed as the company matures can preserve legitimate protections without inadvertently causing friction as the spin-out develops. 

Consistency, standardisation and legal judgement 

In recent years, particularly following the independent review of university spin-out companies and the government’s response, there has been a growing focus on more consistent market practice across the spin-out ecosystem.

In the UK, the USIT guide has become an important reference point, offering a market-informed starting point for negotiating issues such as equity, royalties and key licensing terms. 

The guide is helpful in giving parties a clearer starting point and a better sense of where market practice is developing. At the same time, universities may still have legitimate reasons to depart from benchmark positions based on sector, technology readiness, regulatory burden or prior institutional investment.

For advisers, the guidance provides a valuable and consistent framework which can be used alongside legal and commercial judgement to reflect the particular context and assess how provisions are likely to operate in practice as the relevant spin-out grows. 

Spin-outs and scalability

In most university spin‑outs, the starting position is that the university retains ownership of the underlying IP. A licence can support investment and growth perfectly well if it is drafted with sufficient scope, durability and practical flexibility. However, poorly structured commercial or protective rights can create conflict and stifle growth of the spin-out.  

As universities continue to generate spin-out companies, careful legal structuring remains one of the most effective ways to reduce friction and improve the chances of long-term success. For spin-outs, the real legal question is rarely whether the university keeps ownership of the IP, but whether the licence gives the company enough certainty and freedom to build a scalable business.